Medical Education Content
NEW PHARMA-EXCLUSIVE WEBINAR: Beyond the Hype; Practical, Compliant AI Solutions for Pharma Engagement
See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards
What do HCPs want from pharma medical information sites in 2026?
At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector...
Smarter Learning and Better Outcomes: How AI Can Provide an Advantage in Medical Education
See how AI-powered patient avatars allow physicians to test complex diagnoses and treatment plans in a simulated environment.
From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction
Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the immersive, longitudinal strategies and newly...
New Webinar: 2026 Engagement Strategies For Modern Pharma
Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!
The Future of MSL Training – How Digital Technologies Are Shaping Success
Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.
Learn the golden standard for omnichannel strategies!
Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar to learn how to eliminate silos and turn fragmented data into actionable insights. Register...
Build a KOL Community Virtually – Engaging Your Advisors Creatively
Go beyond formal meetings! Discover a creative way to build a virtual KOL community through ongoing discussion forums. Facilitate peer-to-peer best practice sharing and foster authentic, sustained relationships with your...
Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030
[Dublin, 9th October 2025] Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based Targets initiative (SBTi) goal of halving Scope 1 and...
Streamlining European expansion for cell and gene therapies
Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...
Current CGT landscape and future outlook
What makes CGT unique Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...